LOSARTAN POTASSIUM | A202230 | MACLEODS PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.0435
per ea
Lowest NADAC/Unit
$0.0215
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 33342004644LOSARTAN POTASSIUM 100 MG TAB | $0.0435 | EA | Generic | — | 2026-06-17 |
| 33342004610LOSARTAN POTASSIUM 100 MG TAB | $0.0435 | EA | Generic | — | 2026-06-17 |
| 33342004607LOSARTAN POTASSIUM 100 MG TAB | $0.0435 | EA | Generic | — | 2026-06-17 |
| 33342004544LOSARTAN POTASSIUM 50 MG TAB | $0.0337 | EA | Generic | — | 2026-06-17 |
| 33342004507LOSARTAN POTASSIUM 50 MG TAB | $0.0337 | EA | Generic | — | 2026-06-17 |
| 33342004510LOSARTAN POTASSIUM 50 MG TAB | $0.0337 | EA | Generic | — | 2026-06-17 |
| 33342004410LOSARTAN POTASSIUM 25 MG TAB | $0.0215 | EA | Generic | — | 2026-06-17 |
| 33342004444LOSARTAN POTASSIUM 25 MG TAB | $0.0215 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.